13 MAY 2014 WELL POWER INC (OTCMKTS: WPWR) announced that its company information would be made available via S&P Capital IQ Corporation Records Listing Program. WELL POWER INC (OTCMKTS: WPWR) on last trading day company shares ended up $0.0930.
The latest press release from ERBB concerned a name change set in motion. Tranzbyte should soon trade as American Green. The release outlines the change as ERBB’s ‘primary effort’ to maintain its position as a leader in the MJ market. When ERBB became a leader in the sector is not exactly clear, as the company is still working to launch its flagship ZaZZZ vending machine and has not found a source of sizable revenues just yet.
The latest press release from ERBB concerned a name change set in motion. Tranzbyte Corp (OTCMKTS: ERBB) should soon trade as American Green. The release outlines the change as ERBB’s ‘primary effort’ to maintain its position as a leader in the MJ market. Tranzbyte Corp (OTCMKTS: ERBB) shares fell -9.52%in last trading session and ended the day on $0.0266.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) update and reported financial results for the first quarter ended March 31, 2014. The company’s first quarter revenues totaled $6.8 million, including $2.9 million in net product sales of BELVIQ, of which $2.7 million represented 31.5% of Eisai’s net product sales and $0.2 million related to redemptions of the 15-day free voucher. Net loss was $25.3 million, or $0.12 per share. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares moved down -0.31% in last trading session and was closed at $6.37, while trading in range of $6.08 – $6.39.Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) year to date (YTD) performance is 8.89%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that clinical data on Iclusig® (ponatinib) and AP26113, its investigational oral inhibitor of anaplastic lymphoma kinase (ALK), will be presented at the Annual Meeting of the American Society of Clinical Oncology being held in Chicago, May 30 to June 3, 2014.Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) ended the last trading day at $6.50. Company weekly volatility is calculated as 4.69% and price to cash ratio as 5.12. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) showed a negative weekly performance of -2.55%.
VIVUS, Inc. (NASDAQ:VVUS) announced that a poster describing results of an analysis of the association between weight loss with Qsymia® (phentermine and topiramate extended-release) capsules CIV and annual concomitant medication costs will be presented at the AACE 23rd Annual Scientific & Clinical Congress at the Paris Las Vegas Hotel, Las Vegas, NV.VIVUS, Inc. (NASDAQ:VVUS) weekly performance is -7.99%. On last trading day company shares ended up $4.95. Analysts mean target price for the company is $7.33. VIVUS, Inc. (NASDAQ:VVUS) distance from 50-day simple moving average (SMA50) is -10.16%.
Leave a Reply